Literature DB >> 16193515

Yeast expression of the VP8* fragment of the rotavirus spike protein and its use as immunogen in mice.

Isabel Andrés1, Jesús Rodríguez-Díaz, Javier Buesa, Jesús Zueco.   

Abstract

The VP8* fragment from the rotavirus spike protein was expressed as a fusion protein with two different cell wall proteins of Saccharomyces cerevisiae, Icwp (Ssr1p) and Pir4, to achieve cell wall targeting or secretion to the growth medium of the fusion proteins. Two different host strains were used for the expression of the fusion proteins, a standard S. cerevisiae strain and a mnn9 glycosylation deficient strain, the later to reduce hyper-glycosylation. The Icwp-VP8* fusion could only be detected in the growth medium, indicating that the presence of the VP8* moiety interferes with the anchorage of Icwp to the cell wall. In the case of the Pir4-VP8* fusion proteins, we achieved cell wall targeting or secretion depending on how the gene fusion had been performed. In all cases, the fusion proteins expressed in the mnn9 strain showed a reduced level of glycosylation. Mice were inoculated intraperitoneally either with Pir4-VP8* or Icwp-VP8* fusion proteins purified from the growth medium of mnn9 strains expressing them or with whole cells of an mnn9 strain expressing a Pir4-VP8 fusion protein on its cell walls. Hundred percent of mice inoculated with the Pir4-VP8* fusion protein and 25% of those inoculated with the Icwp-VP8* fusion protein showed high titers of anti-VP8* antibodies. No specific immune response was detected in those mice inoculated with whole cells. Finally, susceptibility to rotavirus infection of the offspring of immunized dams was determined and protection was found in a percentage of approximately 60% with respect to the control group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16193515     DOI: 10.1002/bit.20696

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  5 in total

1.  Efficient expression of a Paenibacillus barcinonensis endoglucanase in Saccharomyces cerevisiae.

Authors:  María Mormeneo; Fi Javier Pastor; Jesús Zueco
Journal:  J Ind Microbiol Biotechnol       Date:  2011-06-24       Impact factor: 3.346

Review 2.  The Rotavirus Vaccine Landscape, an Update.

Authors:  Roberto Cárcamo-Calvo; Carlos Muñoz; Javier Buesa; Jesús Rodríguez-Díaz; Roberto Gozalbo-Rovira
Journal:  Pathogens       Date:  2021-04-26

3.  An Efficient Genome-Wide Fusion Partner Screening System for Secretion of Recombinant Proteins in Yeast.

Authors:  Jung-Hoon Bae; Bong Hyun Sung; Hyun-Jin Kim; Soon-Ho Park; Kwang-Mook Lim; Mi-Jin Kim; Cho-Ryong Lee; Jung-Hoon Sohn
Journal:  Sci Rep       Date:  2015-07-21       Impact factor: 4.379

4.  Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs.

Authors:  Ashwin Ramesh; Jiangdi Mao; Shaohua Lei; Erica Twitchell; Ashton Shiraz; Xi Jiang; Ming Tan; And Lijuan Yuan
Journal:  Vaccines (Basel)       Date:  2019-11-06

5.  Performance of the auxotrophic Saccharomyces cerevisiae BY4741 as host for the production of IL-1beta in aerated fed-batch reactor: role of ACA supplementation, strain viability, and maintenance energy.

Authors:  Lucia Paciello; Elisabetta de Alteriis; Cristina Mazzoni; Vanessa Palermo; Jesus Zueco; Palma Parascandola
Journal:  Microb Cell Fact       Date:  2009-12-30       Impact factor: 5.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.